Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Clostridium difficile heterogeneously impacts intestinal community architecture but drives stable metabolome responses.

Rojo D, Gosalbes MJ, Ferrari R, Pérez-Cobas AE, Hernández E, Oltra R, Buesa J, Latorre A, Barbas C, Ferrer M, Moya A.

ISME J. 2015 Oct;9(10):2206-20. doi: 10.1038/ismej.2015.32. Epub 2015 Mar 10.

2.

Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children.

Ling Z, Liu X, Jia X, Cheng Y, Luo Y, Yuan L, Wang Y, Zhao C, Guo S, Li L, Xu X, Xiang C.

Sci Rep. 2014 Dec 15;4:7485. doi: 10.1038/srep07485.

3.

Shifts in the Gut Metabolome and Clostridium difficile Transcriptome throughout Colonization and Infection in a Mouse Model.

Fletcher JR, Erwin S, Lanzas C, Theriot CM.

mSphere. 2018 Mar 28;3(2). pii: e00089-18. doi: 10.1128/mSphere.00089-18. eCollection 2018 Mar-Apr.

4.

Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection.

Theriot CM, Koenigsknecht MJ, Carlson PE Jr, Hatton GE, Nelson AM, Li B, Huffnagle GB, Z Li J, Young VB.

Nat Commun. 2014;5:3114. doi: 10.1038/ncomms4114.

5.
6.

Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.

Theriot CM, Young VB.

Gut Microbes. 2014 Jan-Feb;5(1):86-95. doi: 10.4161/gmic.27131. Epub 2013 Dec 11. Review.

7.

Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition.

Rousseau C, Levenez F, Fouqueray C, Doré J, Collignon A, Lepage P.

J Clin Microbiol. 2011 Mar;49(3):858-65. doi: 10.1128/JCM.01507-10. Epub 2010 Dec 22.

8.

Circulating antibody and memory B-Cell responses to C. difficile toxins A and B in patients with C. difficile-associated diarrhoea, inflammatory bowel disease and cystic fibrosis.

Monaghan TM, Robins A, Knox A, Sewell HF, Mahida YR.

PLoS One. 2013 Sep 10;8(9):e74452. doi: 10.1371/journal.pone.0074452. eCollection 2013.

9.

Cellular Uptake and Mode-of-Action of Clostridium difficile Toxins.

Papatheodorou P, Barth H, Minton N, Aktories K.

Adv Exp Med Biol. 2018;1050:77-96. doi: 10.1007/978-3-319-72799-8_6. Review.

PMID:
29383665
10.

Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria.

Passmore IJ, Letertre MPM, Preston MD, Bianconi I, Harrison MA, Nasher F, Kaur H, Hong HA, Baines SD, Cutting SM, Swann JR, Wren BW, Dawson LF.

PLoS Pathog. 2018 Sep 12;14(9):e1007191. doi: 10.1371/journal.ppat.1007191. eCollection 2018 Sep.

11.

Fate of ingested Clostridium difficile spores in mice.

Howerton A, Patra M, Abel-Santos E.

PLoS One. 2013 Aug 30;8(8):e72620. doi: 10.1371/journal.pone.0072620. eCollection 2013.

12.

Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.

Knecht H, Neulinger SC, Heinsen FA, Knecht C, Schilhabel A, Schmitz RA, Zimmermann A, dos Santos VM, Ferrer M, Rosenstiel PC, Schreiber S, Friedrichs AK, Ott SJ.

PLoS One. 2014 Feb 28;9(2):e89417. doi: 10.1371/journal.pone.0089417. eCollection 2014.

13.

Clostridium difficile Alters the Structure and Metabolism of Distinct Cecal Microbiomes during Initial Infection To Promote Sustained Colonization.

Jenior ML, Leslie JL, Young VB, Schloss PD.

mSphere. 2018 Jun 27;3(3). pii: e00261-18. doi: 10.1128/mSphere.00261-18. Print 2018 Jun 27.

14.

Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.

Zhang L, Dong D, Jiang C, Li Z, Wang X, Peng Y.

Anaerobe. 2015 Aug;34:1-7. doi: 10.1016/j.anaerobe.2015.03.008. Epub 2015 Mar 26.

PMID:
25817005
15.

Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.

Kaneria MV, Paul S.

J Assoc Physicians India. 2012 Nov;60:26-8.

PMID:
23767199
16.

Recovery of the gut microbiome following fecal microbiota transplantation.

Seekatz AM, Aas J, Gessert CE, Rubin TA, Saman DM, Bakken JS, Young VB.

MBio. 2014 Jun 17;5(3):e00893-14. doi: 10.1128/mBio.00893-14.

17.

Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.

Lin HJ, Hung YP, Liu HC, Lee JC, Lee CI, Wu YH, Tsai PJ, Ko WC.

J Microbiol Immunol Infect. 2015 Apr;48(2):183-9. doi: 10.1016/j.jmii.2013.08.003. Epub 2013 Sep 21.

18.

Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants.

Adlerberth I, Huang H, Lindberg E, Åberg N, Hesselmar B, Saalman R, Nord CE, Wold AE, Weintraub A.

J Clin Microbiol. 2014 Jan;52(1):173-9. doi: 10.1128/JCM.01701-13. Epub 2013 Oct 30.

19.

Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients.

Nycz BT, Dominguez SR, Friedman D, Hilden JM, Ir D, Robertson CE, Frank DN.

PLoS One. 2018 Jan 12;13(1):e0191232. doi: 10.1371/journal.pone.0191232. eCollection 2018. Erratum in: PLoS One. 2018 May 10;13(5):e0197530.

20.

The emerging metabolic view of Clostridium difficile pathogenesis.

Hryckowian AJ, Pruss KM, Sonnenburg JL.

Curr Opin Microbiol. 2017 Feb;35:42-47. doi: 10.1016/j.mib.2016.11.006. Epub 2016 Dec 19. Review.

Supplemental Content

Support Center